BRPI0922406A2 - formulação farmacêutica, e, processo para preparar uma formulação - Google Patents

formulação farmacêutica, e, processo para preparar uma formulação

Info

Publication number
BRPI0922406A2
BRPI0922406A2 BRPI0922406A BRPI0922406A BRPI0922406A2 BR PI0922406 A2 BRPI0922406 A2 BR PI0922406A2 BR PI0922406 A BRPI0922406 A BR PI0922406A BR PI0922406 A BRPI0922406 A BR PI0922406A BR PI0922406 A2 BRPI0922406 A2 BR PI0922406A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
preparing
formulation
pharmaceutical
Prior art date
Application number
BRPI0922406A
Other languages
English (en)
Inventor
Aldo Vincent Ket
Henny Kuil
Jan P Möschwitzer
Lucia Maria Doesborgh-Dewit
Sophia R Van Tomme
Yu-San Wu
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Publication of BRPI0922406A2 publication Critical patent/BRPI0922406A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0922406A 2008-12-19 2009-12-17 formulação farmacêutica, e, processo para preparar uma formulação BRPI0922406A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13919308P 2008-12-19 2008-12-19
EP08172247 2008-12-19
PCT/EP2009/067434 WO2010070057A2 (en) 2008-12-19 2009-12-17 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability

Publications (1)

Publication Number Publication Date
BRPI0922406A2 true BRPI0922406A2 (pt) 2015-12-15

Family

ID=40536155

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922406A BRPI0922406A2 (pt) 2008-12-19 2009-12-17 formulação farmacêutica, e, processo para preparar uma formulação

Country Status (21)

Country Link
US (1) US20110257158A1 (pt)
EP (1) EP2379061B1 (pt)
JP (1) JP5669751B2 (pt)
KR (1) KR20110104059A (pt)
CN (1) CN102395360A (pt)
AR (1) AR074689A1 (pt)
AU (1) AU2009327068A1 (pt)
BR (1) BRPI0922406A2 (pt)
CA (1) CA2747345C (pt)
CO (1) CO6390098A2 (pt)
DO (1) DOP2011000194A (pt)
EA (1) EA019147B1 (pt)
EC (1) ECSP11011138A (pt)
ES (1) ES2393530T3 (pt)
IL (1) IL213604A0 (pt)
MX (1) MX2011006691A (pt)
PE (1) PE20110923A1 (pt)
SG (1) SG172246A1 (pt)
TW (1) TW201028168A (pt)
WO (1) WO2010070057A2 (pt)
ZA (1) ZA201104907B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3523252B1 (en) * 2016-10-05 2026-03-11 Boai NKY Medical Holdings Ltd. Tablet compositions containing crosslinked polyvinylpyrrolidone and their use in beverage applications
KR20250026366A (ko) * 2017-07-05 2025-02-25 노파르티스 아게 신규한 약학적 조성물
KR102227745B1 (ko) * 2017-12-18 2021-03-15 성균관대학교산학협력단 분해도 제어가 가능한 크라이오젤 스캐폴드 및 상기 스캐폴드에 고형암 미세환경에서 면역억제작용을 제어하는 약물을 로딩한 연성 생체삽입소자

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
EP1070741B1 (de) * 1999-07-19 2008-04-09 fit GmbH Coprozessiertes Polysaccharidprodukt mit vernetztem Polyvinylpyrrolidon
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone
US20070020334A1 (en) * 2005-07-11 2007-01-25 Poul Bertelsen Benzimidazole formulation
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles
KR101903781B1 (ko) * 2007-06-06 2018-11-13 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
JP2010529071A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
DE102007027067A1 (de) * 2007-06-12 2008-12-18 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat

Also Published As

Publication number Publication date
EP2379061B1 (en) 2012-11-14
CO6390098A2 (es) 2012-02-29
ECSP11011138A (es) 2011-07-29
SG172246A1 (en) 2011-07-28
JP2012512836A (ja) 2012-06-07
AU2009327068A1 (en) 2011-07-14
IL213604A0 (en) 2011-07-31
PE20110923A1 (es) 2012-01-09
JP5669751B2 (ja) 2015-02-18
WO2010070057A3 (en) 2010-08-19
WO2010070057A2 (en) 2010-06-24
CA2747345A1 (en) 2010-06-24
CA2747345C (en) 2017-05-16
MX2011006691A (es) 2011-07-28
ZA201104907B (en) 2012-03-28
AR074689A1 (es) 2011-02-02
CN102395360A (zh) 2012-03-28
TW201028168A (en) 2010-08-01
DOP2011000194A (es) 2011-07-31
EA201170843A1 (ru) 2012-02-28
ES2393530T3 (es) 2012-12-26
EA019147B1 (ru) 2014-01-30
US20110257158A1 (en) 2011-10-20
EP2379061A2 (en) 2011-10-26
KR20110104059A (ko) 2011-09-21

Similar Documents

Publication Publication Date Title
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0812064A2 (pt) Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica
BRPI0908221A2 (pt) processo para preparar uma formulação farmacêutica de agentes de contraste
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
BRPI0814611A2 (pt) Composição, processo para preparar uma composição, e, uso de uma composição
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0908092A2 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BRPI0921429A2 (pt) formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
BR112012002102A2 (pt) composição farmaceutica e metodo para preparar uma composição farmaceutica
BRPI1016132A2 (pt) composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BRPI1007211A2 (pt) composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição.
BRPI0905847A2 (pt) "composição farmacêutica injetável e processo para preparar a composição"
BRPI0911554A2 (pt) Microemulsão, processo para a preparação de uma microemulsão, e, uso da microemulsão.
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI0814821A2 (pt) Composto, composição farmacêutica, e, processo para preparar um composto
BRPI1010707A2 (pt) composição farmacêutica, processo para o preparo da mesma, processo para o preparo de uma formulação injetável e formulação injetável
BRPI0922714A2 (pt) composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica
BRPI0925100A2 (pt) forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
BRPI0807001A2 (pt) Formulação farmacêutica, e, método para preparação de uma formulação farmacêutica.
BR112013002036A2 (pt) processo para preparar um plastificante, plastificante e composição polimérica
BRPI0815975A2 (pt) Preparação aquosa, recipiente farmacêutico, processo para preparar uma preparação aquosa, e, uso de uma preparação aquosa
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BR112013005986A2 (pt) processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]